Amarin Corp Plc (AMRN)

[Bouf]

TT—I get it. What I am saying is that the generics will rely heavily on the first rule of appellate law that it is up to the trier of fact to decide which witness to believe. AMRN will be left to argue in reply that neither expert, nor the evidence, supports the findings or conclusions made.